Here are Friday's biggest analyst calls: Nvidia, Apple, Tesla, Chipotle, Disney, Robinhood, Coinbase & more

Cnbc · 🇺🇸 public United States · Jun 05, 2026 · 1051 words · By Michael Bloom

AI Sector Growth Stock Market Trends Wall Street Analyst Ratings

headphones Listen to the eFinder podcast briefing

Ready to play

Daily briefing

What to know about AI Sector Growth

Here are Friday's biggest calls on Wall Street: JPMorgan adds a positive catalyst watch on Qualcomm The firm said its sticking with its neutral rating but is bullish ahead of the company's investor day.

Claims checked 31

Techniques found 1

Topics 3

Coverage spectrum

Coverage gap: Low Left coverage

Left0%

Center100%

Right0%

1 source compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Why it matters

" Qualcomm is set to host its highly anticipated Investor Day on June 24th, to discuss the next phase of the company's growth and diversification strategy amidst the rapid evolution of AI." Bank of America reiterates Nvidia as buy Bank of America said the…

Common ground

"Following 'GTC Taipei' CEO keynote on Monday we hosted NVDA CFO Colette Kress for a well-attended keynote on Thursday, and Sr.

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

Follow-up questions

What new context would change how readers understand this AI Sector Growth story?
What evidence would most clearly confirm or weaken the claim that Baird... added a bearish fresh pick on the stock [Coinbase]?
How does this story connect AI Sector Growth with Stock Market Trends over the next few days?

open_in_new Read the original article: https://www.cnbc.com/2026/06/05/friday-biggest-analyst-calls-from-stocks-like-nv…

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning

Loaded Language 70% confidence

Using words with strong emotional connotations to influence an audience.

Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.

Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 31 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 21

check_circle Corroborated 8

info Single Source 1

help Insufficient Evidence 1

schedule

Claim 1: “Baird... added a bearish fresh pick on the stock [Coinbase]”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 2: “Baird reiterates Coinbase as neutral”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 3: “Goldman Sachs initiates Sotera Health as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 4: “Goldman Sachs initiates Guardant Health as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 5: “Deutsche Bank... $350 price target [for Onto Innovation]”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 6: “Deutsche Bank initiates Onto Innovation as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 7: “The firm [Rosenblatt] raised its price target to $126 per share from $121 [for Disney]”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 8: “UBS initiates Champion Homes and Cavco as buy”

CORROBORATED

Both Seeking Alpha and MarketWatch report that UBS initiated coverage on Champion Homes (SKY) and Cavco Industries (CVCO) with Buy ratings.

travel_explore

web search NEUTRAL — UBS initiated coverage of manufactured housing companies Champion Homes (SKY) and Cavco Industries (CVCO) with Buy ratings, arguing that a shortage of affordable housing and signs of stabilization in …
https://seekingalpha.com/news/4601259-champion-homes-cavco-r…

travel_explore

web search NEUTRAL — Discover quality manufactured and modular homes by Cavco, offering customizable designs, energy efficiency, and value.
https://www.cavcohomes.com/?gad=1

travel_explore

web search NEUTRAL — UBS Initiates Buy Ratings for Champion Homes (SKY) and Cavco Industries (CVCO).SKY Initiated Coverage by Citigroup -- Price Target Announced at $93.
https://www.marketwatch.com/investing/stock/sky

schedule

Claim 9: “Bernstein upgrades Kanzhun to outperform from market perform”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 10: “Rosenblatt reiterates Disney as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 11: “Citi upgrades Shattuck Labs to buy from neutral”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 12: “Goldman Sachs initiates Concentra as buy”

CORROBORATED

Multiple sources, including Investing.com and reports on Concentra's stock price, confirm Goldman Sachs initiated coverage on Concentra with a Buy rating.

menu_book

wikipedia NEUTRAL — Welsh, Carson, Anderson & Stowe (WCAS), also referred to as Welsh Carson, is a private equity firm. WCAS was formed in 1979 and focuses on investing the industries of technology and healthcare, primar…
https://en.wikipedia.org/wiki/Welsh,_Carson,_Anderson_&_Stow…

menu_book

wikipedia NEUTRAL — Financeit is a Canadian financial technology company based in Toronto, Ontario. Founded in 2011, it provides point-of-sale financing services to merchants in sectors such as home improvement, retail, …
https://en.wikipedia.org/wiki/Financeit

menu_book

wikipedia NEUTRAL — Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) com…
https://en.wikipedia.org/wiki/Humana

+ 3 more evidence sources

check_circle

Claim 13: “BTIG downgrades Lululemon to hold from buy”

CORROBORATED

Three separate reports from Investing.com and other market news sources confirm BTIG downgraded Lululemon from Buy to Neutral/Hold.

travel_explore

web search NEUTRAL — Jun 5, 2026 ... Investing.com - BTIG downgraded Lululemon Athletica (NASDAQ:LULU) to Neutral from Buy on Thursday, citing decelerating sales trends and ...
https://www.investing.com/news/analyst-ratings/lululemon-sto…

travel_explore

web search NEUTRAL — Jun 5, 2026 ... Markets Hold Steady ... BTIG LLC analyst Janine Stichter downgraded the firm to a neutral rating from a buy on Friday following Lululemon's ...
https://www.bloomberg.com/news/articles/2026-06-05/wall-stre…

travel_explore

web search NEUTRAL — Jun 5, 2026 ... Investing.com -- BTIG downgraded Lululemon Athletica to Neutral from Buy in a note on Friday, citing deteriorating sales trends, ...
https://ca.finance.yahoo.com/news/btig-downgrades-lululemon-…

schedule

Claim 14: “June 4th launch of Rothera, a new prediction exchange managed with Susquehanna as the key liquidity provider”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 15: “JPMorgan upgrades Tesla to neutral from underperform”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info

Claim 16: “JPMorgan adds a positive catalyst watch on Qualcomm”

SINGLE SOURCE

The provided evidence for this claim consists of general Wikipedia entries about JPMorgan Chase and J.P. Morgan, but contains no information regarding a 'positive catalyst watch' on Qualcomm.

travel_explore

web search NEUTRAL — JPMorgan Chase & Co. (stylized as JPMorganChase) is an American multinational banking institution headquartered in New York City and incorporated in Delaware.
https://en.wikipedia.org/wiki/JPMorgan_Chase

travel_explore

web search NEUTRAL — John Pierpont Morgan Sr. (April 17, 1837 – March 31, 1913) was an American financier and investment banker who dominated corporate finance on Wall Street throughout the Gilded Age and Progressive Era.
https://en.wikipedia.org/wiki/J._P._Morgan

travel_explore

web search NEUTRAL — JPMorganChase is honored to be the first global banking partner of the Olympic and Paralympic Games. JPMorganChase serves millions of customers, clients and communities in over 100 global markets. For…
https://www.jpmorganchase.com/

check_circle

Claim 17: “Roth... 12-month PT of $12 [for Coya Therapeutics]”

CORROBORATED

Although the 'Evidence for claim 8' section says no evidence found, the evidence provided for claim 7 explicitly states: 'Roth/MKM initiated coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and a price target of $12.00.'

schedule

Claim 18: “Deutsche Bank reiterates Robinhood as buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 19: “Qualcomm is set to host its highly anticipated Investor Day on June 24th”

CORROBORATED

Multiple independent sources confirm Qualcomm's Investor Day is scheduled for June 24th, including Qualcomm's own site and Investing.com.

menu_book

wikipedia NEUTRAL — BlackRock, Inc. is an American multinational investment company. Founded in 1988, initially as an enterprise risk management and fixed income institutional asset manager, BlackRock is the world's larg…
https://en.wikipedia.org/wiki/BlackRock

menu_book

wikipedia NEUTRAL — U.S. Bancorp (stylized as us bancorp) is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 7th-largest bank in the United St…
https://en.wikipedia.org/wiki/U.S._Bancorp

menu_book

wikipedia NEUTRAL — Younes Nazarian (January 26, 1931 – March 18, 2022) was an Iranian-American businessman, investor, and philanthropist. An early investor in Qualcomm, he was the chairman of Nazarian Enterprises. He wa…
https://en.wikipedia.org/wiki/Younes_Nazarian

+ 3 more evidence sources

check_circle

Claim 20: “Bank of America reiterates Nvidia as buy”

CORROBORATED

The claim is confirmed by a cross-reference from CNBC and multiple web sources including Insider Monkey and other financial reports mentioning analyst Vivek Arya.

travel_explore

web search NEUTRAL — Bank of America has reaffirmed its "Buy" rating on Nvidia (NVDA, Financial) and set a target price of $190. The uplift in price target following Nvidia's strong quarterly results.Truist Financial also…
https://finance.yahoo.com/news/bofa-maintains-buy-nvidia-set…

travel_explore

web search NEUTRAL — On April 28, Bank of America Securities analyst Vivek Arya maintained a Buy rating on Nvidia, according to a report by TipRanks. According to 70 analyst ratings compiled by CNN, 91% gave Nvidia a Buy …
https://www.insidermonkey.com/blog/bank-of-america-maintains…

travel_explore

web search NEUTRAL — Vivek Arya, Bank of America Securities analyst, joins 'Squawk on the Street' to discuss Nvidia's entrance into correction territory, whether competition thre...
https://www.youtube.com/watch?v=hV3tKj3VLFo

+ 1 more evidence source

help

Claim 21: “Evercore ISI upgrades FormFactor to outperform from in line”

INSUFFICIENT EVIDENCE

No evidence was found in the provided search results to support or refute the claim regarding Evercore ISI and FormFactor.

schedule

Claim 22: “Evercore... Upgrade to Outperform with $155 PT [for FormFactor]”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 23: “Goldman Sachs... 12‑month price target of $30 [for Concentra]”

CORROBORATED

Two independent web sources explicitly state that Goldman Sachs set a $30 price target for Concentra.

menu_book

+ 3 more evidence sources

schedule

Claim 24: “JPMorgan upgrades Chipotle to overweight from neutral”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 25: “Goldman Sachs... 12-month price target of $20 [for Sotera Health]”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 26: “Bernstein... PT $18 [for Kanzhun]”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 27: “Berenberg downgrades CrowdStrike to hold from buy”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 28: “Wedbush reiterates Apple as outperform”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 29: “Deutsche Bank raised its price target to $98 per share from $88 on Robinhood”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 30: “Roth initiates Coya Therapeutics as buy”

CORROBORATED

Both Investing.com and MarketWatch confirm that Roth/MKM (Roth Capital) initiated coverage on Coya Therapeutics with a Buy rating.

travel_explore

web search NEUTRAL — May 6, 2026 ... Investing.com - Roth/MKM initiated coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and a price target of $12.00. The stock ...
https://ng.investing.com/news/stock-market-news/rothmkm-init…

travel_explore

web search NEUTRAL — According to 6 analysts, the average rating for COYA stock is "Strong Buy." The 12-month stock price target is $15.21, which is an increase of 168.73% from the ...
https://stockanalysis.com/stocks/coya/

travel_explore

web search NEUTRAL — COYA Initiated Coverage by Roth Capital -- Rating Set to Buy. COYA Initiated Coverage by Roth Capital -- Rating Set to Buy. Jun. 5, 2026 at 8:00 a.m. ET on ...
https://www.marketwatch.com/investing/stock/coya

schedule

Claim 31: “Citi... opening a 30-day positive catalyst watch on STTK”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.